Axonics, Inc. (AXNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

58.71

-0.96

(-1.62%)

As of 12:43PM EST. Market open.

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Business Wire
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
IRVINE, Calif., January 31, 2023--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced that the U.S. Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation system.
Zacks
Axonics (AXNX) Soars 10.6%: Is Further Upside Left in the Stock?
Axonics (AXNX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Simply Wall St.
When Will Axonics, Inc. (NASDAQ:AXNX) Breakeven?
We feel now is a pretty good time to analyse Axonics, Inc.'s ( NASDAQ:AXNX ) business as it appears the company may be...

Advertisement